This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
ProMab
product type :
antibody
product name :
Mouse Monoclonal Antibody to APOA1
catalog :
20191
quantity :
100μl
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
5F4F5
The same clone is also sold as:
The same clone is also sold as:
- Invitrogen: MA5-15391
- MyBioSource: MBS850529, MBS532724
- OriGene: AM06220SU-N
reactivity :
human
application :
western blot, ELISA
product information
Catalog :
20191
Title :
Mouse Monoclonal Antibody to APOA1
Species :
Human
Clone :
5F4F5;
lsotype :
Mouse IgG1
Size :
100μl
Storage :
4℃; -20℃ for long term storage
Description :
APOA1: apolipoprotein A-I, it is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. Defects in the Apolipoprotein A I gene are associated with HDL deficiency and Tangier disease. The therapeutic potential of apoA-I has been recently assessed in patients with acute coronary syndromes, using a recombinant form of a naturally occurring variant of apoA-I. The availability of recombinant normal apoA-I should facilitate further investigation into the potential usefulness of apoA-I in preventing atherosclerotic vascular diseases.
Immunogen :
Purified recombinant fragment of human APOA1 expressed in E. Coli.
Formulation :
Ascitic fluid containing 0.03% sodium azide.
Applications :
ELISA: 1/10000; WB: 1/500 - 1/2000
References :
1. J Mol Med. 2006,Jul, 84(7):561-72. Epub 2006 May 17. ; 2. Clin Endocrinol (Oxf). 2006,Mar, 64(3):260-4.
Type :
Monoclonal Antibody
MW :
25kDa
Aliases :
MGC117399
company information
ProMab
5221 Central Avenue, Suite 200
Richmond, CA 94804
Richmond, CA 94804
info@promab.com
http://www.promab.com1-866-339-0871
headquarters: USA
questions and comments